To determine the relative amount of CCR2+HSC-derived cells vs. CCR2−HSC-derived cells that upregulate a suppressive phenotype, we injected 5 × 105 of either DsRed+CCR2+HSC or GFP+CCR2−HSC into tumor-bearing mice. This evidence concerns the gene CCR2 and neoplasm.